Reven pharmaceuticals stock

2020-02-19 06:42

Reven Pharmaceuticals. The company's medical services offer products for the treatment of vascular diseases such as critical limb ischemia, peripheral arterial disease, coronary artery disease and endothelial dysfunction, enabling patients to get advanced products for their diseases and recover faster.Welcome to Reven Pharmaceuticals. com reven pharmaceuticals stock

Detailed Profile of REVEN PHARMACEUTICALS, INC. portfolio of holdings. SEC Filings include 13F quarterly reports, 13DG events and more.

Reven Pharmaceuticals, Inc. is a developmentstage biopharmaceutical company that develops and markets propriety solutions for the treatment of cardiovascular and circulatory related conditions. REVEN. is a global healthcare company with more than. 10 years of innovation and leadership in vascular care. reven pharmaceuticals stock Reven Housing REIT Inc. Reven Housing REIT, Inc. engages in the acquisition, ownership and operation of portfolios of leased singlefamily homes. It owns properties in Florida, Georgia, Mississippi,

Feb 18, 2019 Company Overview. Reven Pharmaceuticals, Inc. researches, develops, and manufactures products for the treatment of vascular diseases. The company offers products for treatment of critical limb ischemia, peripheral arterial, coronary artery, endothelial dysfunction, and acute ischemic stroke. Its product include Rejuveinix, reven pharmaceuticals stock BBB's Business Review for Reven Pharmaceuticals Inc, Business Reviews and Ratings for Reven Pharmaceuticals Inc in Sarasota, FL.

Rating: 4.47 / Views: 724

A list of my favorite links